# PRESS RELEASE 2017

- # [FDA approves Ferring’s CLENPIQ™ (sodium picosulfate, magnesium oxide, and anhydrous citric acid) oral solution for colonoscopy prep](/content/fda-approves-ferrings-clenpiq-sodium-picosulfate-magnesium-oxide-and-anhydrous-citric-acid-oral-solution-for-colonoscopy-prep/index.html)

The U.S. Food and Drug Administration (FDA) has granted Ferring Pharmaceuticals Inc. approval to market CLENPIQ™ (sodium picosulfate,…

- # [New Ferring and Aché Laboratórios Farmacêuticos facility opens to optimise drug delivery using nanotechnology](/content/new-ferring-and-ache-laboratorios-farmaceuticos-facility-opens-to-optimise-drug-delivery-using-nanotechnology/index.html)

Ferring Pharmaceuticals and Aché Laboratórios Farmacêuticos today announced the inauguration of their joint nanotechnology centre in São Paulo…

- # [Ferring receives Swiss approval for Rekovelle®, the first personalised fertility treatment using an approved dosing algorithm](/content/ferring-receives-swiss-approval-for-rekovelle-the-first-personalised-fertility-treatment-using-an-approved-dosing-algorithm/index.html)

Ferring Pharmaceuticals announced today that Swissmedic has approved Rekovelle® (follitropin delta) for use in controlled stimulation…

- # [Ferring strengthens growth hormone franchise Zomacton® through acquisition of ZomaJet™ needle-free injector device](/content/ferring-strengthens-growth-hormone-franchise-zomacton-through-acquisition-of-zomajet-needle-free-injector-device/index.html)

Ferring Pharmaceuticals announced today that it has entered into a definitive agreement with Antares Pharma, Inc…

- # [Ferring appoints Klaus Dugi as Executive Vice President and Chief Medical Officer](/content/ferring-appoints-klaus-dugi-as-executive-vice-president-and-chief-medical-officer/index.html)

Ferring Pharmaceuticals announced today that Professor Klaus Dugi has been appointed Executive Vice President and Chief Medical Officer…

- # [Ferring announces new analysis of Rekovelle® data relating to personalised medicine in fertility patients](/content/ferring-announces-new-analysis-of-rekovelle-data-relating-to-personalised-medicine-in-fertility-patients/index.html)

Ferring Pharmaceuticals announced today a new analysis of Rekovelle® (follitropin delta) data that showed cumulative live birth rates were similar…

- # [Ferring appoints Lars Peter Brunse to Executive Board](/content/ferring-appoints-lars-peter-brunse-to-executive-board/index.html)

Ferring Pharmaceuticals announced today that Lars Peter Brunse has been appointed Executive Vice President and Chief Production Officer…

- # [Paul Navarre joins Ferring Pharmaceuticals as Chief Executive Officer of Ferring Holding Inc.](/content/paul-navarre-joins-ferring-pharmaceuticals-as-chief-executive-officer-of-ferring-holding-inc/index.html)

Ferring Pharmaceuticals announced today that Paul Navarre has been appointed Chief Executive Officer of Ferring Holding Inc…

- # [Ferring appoints Aaron Graff to Executive Board](/content/ferring-appoints-aaron-graff-to-executive-board/index.html)

Ferring Pharmaceuticals announced today that Aaron Graff has been appointed Executive Vice President and Chief Commercial Officer…

- # [Ferring commits $10 million to March of Dimes to expand research needed to end preterm birth](/content/ferring-commits-10-million-to-march-of-dimes-to-expand-research-needed-to-end-preterm-birth/index.html)

Ferring Pharmaceuticals and the March of Dimes Foundation announced today that Ferring has committed $10 million to support…